ECMO patient outcomes and quality of life study
Part of Heart & circulation, Lungs & breathing clinical trials.
This study follows people who are on ECMO (a machine that supports heart and lung function) to see how they do and what their quality of life is like afterward. It helps doctors learn more about long-term recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You started ECMO (a machine that helps your heart and lungs) within the last 24 hours.
- You or your family member or guardian can give written permission for the study.
- You can communicate in German, English, or a local language the study team understands.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what helps determine survival and better brain function after people are treated with ECMO, a heart-lung support machine. It may help doctors understand who is most likely to do well after this kind of emergency treatment.
This study looks at children (ages 1 day to 18 years) in mainland China who were treated with ECMO during the past 10 years. It aims to understand how ECMO was used and how care outcomes may have differed for children.
This study looks at how well the ECMO machine works in high-altitude areas. It tests the oxygen exchange in the machine to help improve care for patients at high elevations.
This trial tests whether giving more or fewer red blood cell transfusions is better for adult patients on ECMO (a machine that helps your heart and lungs work). The goal is to find the best transfusion approach to improve outcomes.
This study looks at the results (outcomes) for adults who are receiving VA ECMO, a heart-lung life support machine. The goal is to better understand how patients do while on this type of support.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
Hear when a new Extracorporeal Membrane Oxygenation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.